Using emodin to treat heart damage caused by alcohol
Developing natural compound emodin as a therapy for alcoholic cardiomyopathy
This study is looking at how a natural compound called emodin might help protect the heart from damage caused by heavy drinking, and it's aimed at finding a new treatment for people with alcoholic cardiomyopathy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Acepre, LLC NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10808869 on NIH RePORTER |
What this research studies
This research focuses on alcoholic cardiomyopathy (ACM), a serious heart condition caused by excessive alcohol consumption. The project aims to develop emodin, a natural compound known for its anti-inflammatory and protective properties, as a potential therapy for ACM. Researchers will investigate how emodin can prevent heart damage by targeting specific cellular mechanisms involved in the disease. The study will involve preclinical testing to assess the effectiveness and safety of emodin in treating heart issues related to alcohol use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alcoholic cardiomyopathy or those experiencing heart issues related to chronic alcohol use.
Not a fit: Patients who do not consume alcohol or have heart conditions unrelated to alcohol use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for patients suffering from heart damage due to alcohol consumption.
How similar studies have performed: Previous research has shown promise in using natural compounds like emodin for heart-related conditions, indicating potential for success in this approach.
Where this research is happening
Columbia, United States
- Acepre, LLC — Columbia, United States (Active)
Researchers
- Principal investigator: Carver, Wayne E — Acepre, LLC
- Study coordinator: Carver, Wayne E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.